Disease-free survival | ||
---|---|---|
Factors | HR (95% CI) | P value |
All patients (728) | ||
pT stage (3–4 versus 1–2) | 2.51 (1.40–4.50) | 0.002 |
pN stage (positive versus negative) | 2.44 (1.62–3.66) | <0.0001 |
Ki67 (positive versus negative) | 1.59 (1.08–2.34) | 0.02 |
Node-positive patients (278) | ||
pT stage (3–4 versus 1–2) | 2.51 (1.40–4.50) | 0.002 |
ER-β (positive versus negative) | 1.55 (1.93–2.57) | 0.09 |
Node-negative patients (450) | ||
ER-β (negative versus positive) | 1.76 (0.95–3.24) | 0.07 |
Ki67 (positive versus negative) | 2.16 (1.15–4.04) | 0.02 |